Protara Therapeutics Inc

NASDAQ:TARA   9:39:56 AM EDT
7.12
-0.12 (-1.66%)
Other Pre-Announcement

Protara Therapeutics Announces Results From Study Of Cholestasis And Parenteral Nutrition

Published: 09/13/2021 12:57 GMT
Protara Therapeutics Inc (TARA) - Protara Therapeutics Announces Results From a Retrospective Study Evaluating Prevalence of Cholestasis in Patients Dependent on Parenteral Nutrition.
Protara Therapeutics- Expects to Use Results From Completed Retrospective & Ongoing Prospective Study to Inform Next Steps for Its Iv Choline Chloride Development Program.